Navigation Links
Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
Date:7/1/2008

aara, CEO and co-founder of Northern Antibiotics Ltd.

"The need for well-tolerated antibiotics that are active against multidrug-resistant Gram-negative bacteria is urgent. Enteric bacteria are responsible for more than 80% of all the hospital infections caused by Gram-negative bacteria, and now they are rapidly becoming resistant to most antibiotics that are currently used to treat them. Plasmid-mediated carbapenemases, probably transferred from Klebsiella pneumoniae, have now been found in E. coli, the clinically most important species of Gram-negative enteric bacteria. Also plasmid-mediated methylases that cause resistance to all aminoglycosides have been encountered. Finally and quite alarmingly, a single genetic element conferring transferable resistance to carbapenems, aminoglycosides and fluoroquinolones has been reported in K. pneumoniae. One does not need to be very smart to guess what follows when these plasmids become more common and the resulting extremely multidrug-resistant strains start to spread."

About Northern Antibiotics Ltd.

Founded in 2003 and headquartered in Helsinki, Finland, Northern Antibiotics Ltd is engaged in the discovery and development of novel antibiotics against multidrug-resistant Gram-negative bacteria. For more information, visit http://www.northernantibiotics.com.

Contact:

Dr. Barry Mason

Business Development Consultant

Email: barry.mason@northernantibiotics.com

Phone: +44(0)1625-858396

Mobile: +44(0)7713-261356


'/>"/>
SOURCE Northern Antibiotics Ltd
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
2. ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
3. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
4. Nventa Develops Proprietary Vaccine Adjuvant
5. Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
6. DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
7. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
8. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
9. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
10. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
11. New Data on MAGE-A3 Cancer Immunotherapy Support Potential Novel Options of Treating Non-Small Cell Lung Cancer and Melanoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., Nov. 5 Transcept Pharm...rmaceutical company focused on the development and...dress important therapeutic needs in the field of ...st and teleconference with management to discuss t...ovember 12, 2009, at 5:00 p.m. Eastern Standard Ti...
(Date:11/5/2009).... 5 Renee Cobos, MD, a board certi...atology at the University of California, Irvine, a...tremendous results with Thermage CPT®. The up...g and contouring, features a new vibrating hand pi... patient comfort. ,, "Thermage has always been...
(Date:11/5/2009)...wire-FirstCall/ -- Air Methods Corporation (Nasdaq...eptember 30, 2009. Revenue increased 3% to $137.6...er. For the nine-month period, revenue increased ...e prior-year nine-month period. The prior-year qu...in revenue generated from hurricane response activ...
Breaking Medicine Technology:Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2Air Methods Reports 3Q2009 Results and 4Q2009 Update 2Air Methods Reports 3Q2009 Results and 4Q2009 Update 3Air Methods Reports 3Q2009 Results and 4Q2009 Update 4Air Methods Reports 3Q2009 Results and 4Q2009 Update 5Air Methods Reports 3Q2009 Results and 4Q2009 Update 6Air Methods Reports 3Q2009 Results and 4Q2009 Update 7Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States 49282 1Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States 49282 2Leading Healthcare Group Selects Varian Medical Systems to Supply Cancer Treatment Technology for Treatment Centers Across the Western United States 49282 3Loan Repayment Legislation Includes Physical Therapists as Frontline Providers 49280 1Loan Repayment Legislation Includes Physical Therapists as Frontline Providers 49280 2Health Reform Press Conference on June 18 3A Which Bills Will Preserve Privacy Rights and Patient Choice 3F 49278 1
...7 Scientists have identified mutations in a gene ...ren with acute lymphoblastic leukemia (ALL). Altho...is needed to determine how changes in the gene, ca..., the findings are likely to provide the basis for...atment failure. By using a molecular test to ident...
...7 ImQuest Life Sciences announced today the succe... and Drug Administration to initiate human clinica...tor IQP-0410. ImQuest anticipates initiating their...-0410 is a novel small molecule inhibitor of HIV w...nscriptase inhibitor (NNRTI). The compound possess...
Other Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2
(Date:11/6/2009)..., VANCOUVER, Nov. 6 /PRNewswire-FirstCall/ - Card...y announced that it will report financial results ...the morning of Monday, November 9, 2009. Cardiome ...0am Eastern (6:00am Pacific) on that day to discus..., please dial 416-695-7806 or 888-789-9572 and ref...
(Date:11/6/2009)...PRNewswire/ -- The Leukemia & Lymphoma Socie... Give & Get program, which in its first two ca... than $1 million to support LLS,s blood cancer res...rvices. ,, During the campaign, taking place fr...wnloadable 30% discount coupons participants can...
(Date:11/6/2009)...-USNewswire/ -- The U.S. bishops sent an urgent me...r 6, as House members steeped themselves in debate...h care reform bill. ,, Moments before meeting t...hops called for "a fair process" that would permit...ent federal law on abortion funding and conscience...
(Date:11/6/2009)...entific organizations specializing in infectious d...ama today expressing their significant concern wit...ersonal protective equipment (PPE) by healthcare w... 2009 H1N1 influenza. The Society for Healthcare...seases Society of America (IDSA) and the Associati...
(Date:11/6/2009)...as years go by, researcher says , , FRID...ts that people with multiple sclerosis who have re... are more likely to suffer from severe limitations... , The findings, published Nov. 4 in Neurology...ithin five years of developing it are nearly 50 pe...
Breaking Medicine News(10 mins):Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:Get a Jump on Your Holiday Shopping and Give Two Gifts This Season: One to Your Loved Ones and One to People Battling Blood Cancer 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 2Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 3Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 4Health News:Bishops to House: Keep Abortion Funding Out of Health Care Reform, Make Health Care Available to Vulnerable 5Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News:Early Relapse of MS May Mean Fewer Issues Later 2
...s California medical practice,s oldest ,test-tube ...et at 25th anniversary reunion , , SAN RAMON, Ca...h 18, 1985, became the first "IVF baby" born in th...Science Center of the San Francisco Bay Area (RS...
...ay 31 Telik, Inc. (Nasdaq: TELK ) today announc...American Society of Clinical Oncology (ASCO) in Or... 3 randomized, multinational study of TELCYTA(R) (...varian cancer. , , Study Design : Patients with...
...d. announces that the first clinical series using ... Disease Week (DDW), Chicago May 30-June 4th entit...atment of Difficult Biliary Stones Utilizing Peror...9.3mm and impacted stones in 18 of the 31 patients...
... (NYSE: DVA ), a leading provider of kidney care...disease (CKD), today announced the DaVita Glomerul...iPhone and iPod Touch has been downloaded by patie...es where the application has been downloaded inclu...
... Francisco-to-Los Angeles ride May 31 , , SAN FRA...cyclists from 41 states and 14 nations will stream...geles as participants in the colorful and emotiona...related services at the L.A. Gay & Lesbian Cen...
...I a Key Presence at Recent BIO International Conve...B) May 31, 2009 -- Aderans Research Institute Inc....ternational Convention. The leading hair regenera...held May 18-21 at the Georgia World Congress Cente...
Other Medicine News:Health News:Found: First IVF Baby Born in East Bay 25 Years Ago 2Health News:Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer 2Health News:Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer 3Health News:Telik Presents Results at ASCO From ASSIST-5 Trial of TELCYTA in Platinum Refractory and Resistant Ovarian Cancer 4Health News:Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology 2Health News:Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology 3Health News:Lumenis(R) Presents the SlimLine(TM) GI Laser Fiber: The Latest Advancement in Laser Lithotripsy for Gastroenterology 4Health News:DaVita's Kidney Calculator iPhone App Downloaded in 24 Countries 2Health News:DaVita's Kidney Calculator iPhone App Downloaded in 24 Countries 3Health News:AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS 2Health News:AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS 3Health News:AIDS/LifeCycle 8 to Raise $10.5 Million to Fight AIDS 4Health News:Aderans Research BIO International Press Release 2Health News:Aderans Research BIO International Press Release 3
20 g MVR Knife
Full Handle Laseredge Spoon Blade Knife, 3.0 mm angled double bevel
Full Handle Laseredge Slit Blade Knife, 3.2 mm angled double bevel
Full Handle Laseredge Slit Blade Knife, 3.0 mm angled bevel up
Medicine Products: